EDGAR Filing Documents for 0001171843-14-001636

Form 8-K - Current report:

SEC Accession No. 0001171843-14-001636

Filing Date

2014-04-08

Accepted

2014-04-08 16:28:56

Documents

Period of Report

2014-04-08

Items

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	f8k_040814.htm	8-K	29143
2	EXHIBIT 99.1	exh_991.htm	EX-99.1	1058452
3	EXHIBIT 99.2	exh_992.htm	EX-99.2	12537
4	EXHIBIT 99.3	exh_993.htm	EX-99.3	12154
5	EXHIBIT 99.4	exh_994.htm	EX-99.4	10698
6		logo.jpg	GRAPHIC	21163
7		cst.jpg	GRAPHIC	29780
8		tekmira.jpg	GRAPHIC	22060
9		graph.jpg	GRAPHIC	44278
10		proxy.jpg	GRAPHIC	159731
	Complete submission text file	0001171843-14-001636.txt		1506358

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8

Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200

TEKMIRA PHARMACEUTICALS Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 14751399
SIC: 2834 Pharmaceutical Preparations